Lactulose
Brand names: Lactulose, Duphalac
Lactulose is an osmotic laxative used for constipation and for the treatment and prevention of hepatic encephalopathy.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UKDOSAGE AND ADMINISTRATION Oral Adult: The usual adult, oral dosage is 2 to 3 tablespoonfuls (30 to 45 ml, containing 20 g to 30 g of lactulose) three or four times daily. The dosage may be adjusted every day or two to produce 2 or 3 soft stools daily. Hourly doses of 30 to 45 ml of Lactulose may be used to induce the rapid laxation indicated in the initial phase of the therapy of portal-systemic encephalopathy. When the laxative effect has been achieved, the dose of lactulose may then be reduced to the recommended daily dose. Improvement in the patient's condition may occur within 24 hours but may not begin before 48 hours or even later. Continuous long-term therapy is indicated to lessen …
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2022-06-01. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Clinical monograph
How it works
A non-absorbed disaccharide that osmotically draws water into the bowel; in hepatic encephalopathy it also acidifies the colon and reduces ammonia absorption.
Prescribing in practice
- For constipation it may take a day or two to work and commonly causes flatulence and cramps initially.
- Avoid in galactosaemia and intestinal obstruction.
- In hepatic encephalopathy the dose is titrated to achieve a target number of soft stools per day.
Monitoring
Review bowel habit; in hepatic encephalopathy titrate to the target stool frequency and monitor mental state.
Counselling the patient
- It can take 1-2 days to work.
- Some bloating or wind is common at first and usually settles.
- Keep up your fluid intake.
Evidence & guidelines
A first-line osmotic laxative for constipation and standard therapy in hepatic encephalopathy.
Reference: EASL HE Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- IABP Timing Assessment · Mechanical Circulatory Support
- Child-Pugh Score · Liver Disease
- West Haven Criteria for Hepatic Encephalopathy · Hepatology
- Stool Osmotic Gap · GI Assessment
- Rome IV Diagnostic Criteria for Functional Constipation · Functional GI Disorders
- West Haven Criteria for Hepatic Encephalopathy Staging · Liver Disease
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5